Who Will Control Access to New Alzheimer’s Treatments?
Amplifying the Voices of Alzheimer’s: ICER Toolkit
ICER Lowballs Critical Alzheimer’s Medications
Who Decides? How Prescription Drug Affordability Boards Impact Patient Access
IgG4-RD Initiative Meeting Summary
More than one-third of Americans haven’t filled a prescription due to cost: survey
Huntington’s Disease: The Need for a Cure
Overburdened by Alzheimer’s: The Need for Care, Innovation and Access
Meeting Mental Health Patients Where They Are
Who Decides? Pharmacy Benefit Managers & Medication Access
